This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Randomised Double-blind Phase IIa Study (with Co...
Clinical trial

A Randomised Double-blind Phase IIa Study (with Combination Safety Run-in) to Assess the Safety and Efficacy of AZD4547 in Combination with Exemestane vs. Exemestane Alone in ER + Breast Cancer Patients with EGFR Polysomy or Gene Amplification Who Have Pr

Read time: 1 mins
Last updated:23rd Jul 2010
The main objectives of this trial are to assess the safety and tolerability and to determine a dose of AZD4547 in combination with a standard dose of exemestane. Also to assess the relative efficacy of AZD4547 in combination with exemestane compared with exemestane alone by comparison of the change in tumour size at 12 weeks.
Category Value
Study start date 2010-07-23

View full details